EnGeneIC
0 followers
EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.
Org chart
Board & advisors
Mark Levitt
Board Member
Bryan Williams
Board Member
Bruce Stillman
Scientific Advisor
Ian Frazer
Scientific & Clinical Advisor
John Bacon
Advisor
Robert Frederick Seamark
Scientific Advisor
Kulvinder Singh Saini
Advisor